NCT03467360 2026-01-20
ICAR
Centre Antoine Lacassagne
Phase 1 Recruiting
Clinical Trials
5 trialsNCT04082286 2021-06-25
Yttrium-90 Anti CD66 Monoclonal Antibody in Childhood Relapsed/Refractory Leukaemia
Great Ormond Street Hospital for Children NHS Foundation Trust
Phase 1 Completed
NCT00302757 2014-05-29
Radioimmunotherapy With 90Y-ibritumomab Tiuxetan as Part of a Dose Reduced Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation for the Treatment of Non-Hodgkin Lymphoma
University Hospital Tuebingen
Phase 1/2 Completed
NCT00002554 2010-03-30
Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse
Fred Hutchinson Cancer Center
Phase 2 Completed
NCT00177554 2008-05-29
Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma
University of Pittsburgh
Phase 2 Completed